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Background: Infection of long bones after surgery with internal fixation is a challenging 
complication and causes significant morbidity. However, there is still limited data available 
on clinical characteristics, valid treatment options and long-term outcome. The aim of this 
study is to analyze risk factors for internal fixation device-associated infections and to 
evaluate the newly implemented treatment concept at our center.  
Methods: We performed a retrospective study of patients treated for an internal fixation 
device-associated infection from January 2010 to October 2017 in a tertiary healthcare 
center. All data was collected with a case report form (CRF). We compared the 
characteristics of infection after internal extra- (IEIF) and intramedullary fixation (IIIF). In 
04/2013, a dedicated interdisciplinary team was established, and a standardized surgical 
and antimicrobial treatment concept was implemented. Outcome before and after 
establishment of the new treatment strategy was evaluated with chi-square test and 
Kaplan-Meier survival method was employed for outcome analysis.  
Results: We reviewed 127 patients (89 males) with a median age of 53 years. In the two 
groups, IEIF and IIIF patient’ characteristics were similar. Comparing the infection side, 
open fractures were significantly more common in the IIIF than in the IEIF-group (24 vs. 
16 patients; p<0.001). In the IEIF group, retention of the implant (p=0.026) and 
inadequate antibiotic treatment (p=0.023) were significant risk factors for a failure. 
Relapsing or persistent infection was observed in 33 (30%) patients. In the patient cohort 
with the standardized treatment concept, significantly less patients showed a persisting 
or relapsing infection compared to the group with the non-standardized treatment (n=16 
(22%) vs. 17 (46%); p=0.015). Among the 78 infection-free patients, 24 reported impaired 
functional outcomes (nonunion, Girdlestone situation or amputation of the limb).  




Conclusion: Several factors for internal fixation device-associated infections have been 
identified, while the outcome was considerably better after implementation of a 
standardized treatment algorithm. A few risk factors for internal fixation device-associated 
infections were found. However, long-term treatment outcome of infections after internal 
fixation of the long bones is still improvable and further advancement of treatment 

























Hintergrund: Infektionen der langen Röhrenknochen nach Implantation von interner 
Fixation sind eine schwerwiegende Komplikation, welche zu einer Steigerung der 
Mortalität der betroffenen Patienten führen. Bisher mangelt es an Daten bezüglich des 
klinischen Krankheitsbildes, suffizienter Therapiekonzepte und der langfristigen 
Ergebnisse bei Infektionen assoziiert mit interner Fixation. 
Methoden: Wir führten eine retrospektive Studie mit Patienten durch, die an einer 
Infektion der langen Röhrenknochen als Folge der Implantation von interner Fixation 
erkrankt waren. In die Studie eingeschlossen wurden Patienten, die im Zeitraum von 
Januar 2010 bis Oktober 2017 im Centrum für Muskuloskeletale Chirurgie der Charité 
behandelt wurden. Die Daten wurden in einem dafür angelegten Formular (CRF) erfasst. 
Zum einen verglichen wir Infektionscharakteristika bei interner extramedullärer (IEIF) 
versus interner intramedullärer Fixation (IIIF). Im April 2013 wurde, mit Hilfe eines 
interdisziplinären Teams, ein neues standardisiertes chirurgisches und antimikrobielles 
Therapiekonzept eingeführt. Somit verglichen wir zum anderen die Langzeitergebnisse 
der Patienten die vor bzw. nach der Einführung dieses Therapiekonzeptes behandelt 
wurden. Angewendet wurden der Chi-Quadrant-Test sowie die Kaplan-Meier-Schätzung. 
Ergebnisse: Eingeschlossen in die Studie waren 127 Patienten (89 männliche) mit 
einem mittleren Alter von 53 Jahren. In den beiden Kohorten (IEIF vs. IIIF) waren die 
Patientencharakteristika vergleichbar. Im Vergleich der Indikation für die interne Fixation, 
waren offene Frakturen signifikant häufiger der Grund in der IIIF- als in der IEIF-Kohorte 
(24 vs. 16 Patienten; p<0,001). In der Patientenkohorte mit IEIF stellten sich die 
Beibehaltung des Implantats (p=0,026) und ein inadäquates antibiotisches 
Therapiekonzept (p=0,023) als signifikante Risikofaktoren für ein Therapieversagen 
heraus. Eine wiederkehrende oder persistierende Infektion wurde bei 33 (30%) Patienten 




gesehen. In der Kohorte, welche nach der Einführung des standardisierten 
Therapiekonzepts behandelt wurden, zeigten sich signifikant weniger persistierende oder 
wiederkehrende Infektionen, als in der Kohorte vor der Einführung des 
Therapiestandards (n=16 (22%) vs. 17 (46%); p=0,015). Unter den 78 Patienten mit einer 
erfolgreichen Infektionseradikation, wiesen 24 eine Funktionsbeeinträchtigung 
(Pseudarthose, Gridlestone-Situation oder Amputation der betroffenen Extremität) vor.  
Schlussfolgerung: Zum einen konnten Risikofaktoren für eine Infektion als Folge einer 
Implantation einer internen Fixation identifiziert werden. Zum anderen zeigte sich, eine 
Besserung der Langzeitergebnisse für Patienten, die nach der Einführung des 
standardisierten Therapiekonzeptes behandelt wurden. Insgesamt bleibt zu sagen, dass 
diagnostische und therapeutische Konzepte standardisiert und optimiert werden 
müssten, um Infektionen nach Implantation von interner Fixation häufiger erfolgreich zu 
therapieren und somit die Mortalität für diese Patienten zu senken.   
  




1.  Introduction 
Internal fixation of long bones is a widely used procedure for different situations in 
orthopedic and traumatological practice. Infections after internal fixation of the long bones 
are a devastating complication and cause significant morbidity. Comprehensive treatment 
algorithms were established in recent years (1-8). However, data about clinical 
characteristics and treatment outcome is still limited. 
 
1.1 Internal Fixation 
Internal fixation of long bones is performed for different indications and can be 
accomplished with various types of materials such as intramedullary nails, screws and 
pins, generating different degrees of stability. Various indications for internal bone fixation 
are reviewed in the following paragraphs. 
 
1.1.1 Fracture fixation 
Posttraumatic internal fixation can be challenging due to the severity of bone and 
concomitant soft tissue damage (1). The methods of internal fixation after fracture are 
classified according to the grade of stability into techniques resulting in absolute stability 
and techniques with relative stability (9). Absolute stability is achieved with 
interfragmentary compression plating, which is used for articular, metaphyseal and 
diaphyseal fractures. It allows a direct fracture healing while taking off the strain on the 
fracture site. The downside to this approach is the compromised local blood supply due 
to the stiff contact of the plate to the surface of the bone. This may cause necrosis of the 
bone and thereby increase the risk of infection (10). A new type of plates, the locking 
compression plates (LCP) are noncontact plates, which lower the risk of impaired blood 




flow and their inherent consequences. Techniques with relative stability such as 
intramedullary nailing or use of bridging plates allow for small interfragmentary 
movements to take place. The union of the bone is achieved through indirect bone 
healing.  
Intramedullary nails exist in a reamed or unreamed type. Unreamed nails hold the 
advantage of not requiring widening of the medullary canal in advance. Reaming of the 
medullary canal bears its own risks, such as increase of the intracavity pressure and 
temperature which may eventually lead to damage of the cortical lamella and bone 
necrosis (9). Nevertheless, according to the current knowledge reamed nailing has a 
significantly lower risk of nonunion or implant failure (9, 11, 12). 
In the upper extremity, plates and intramedullary nails are commonly used for internal 
fracture fixation. In fractures of the lower extremity, intramedullary nails are preferred 
because this technique allows for earlier weight bearing. In cases of shaft fractures or 
extended fractures involving the metaphysis or the joint, intramedullary nailing is not 
sufficient. For surgical treatment planning, the condition of the soft tissue, the quality of 
the fractured bone (e.g. osteoporosis) and the cause of the facture (e.g. pathologic 
fracture) should be considered (9, 12). 
 
Figure 1: Patient with open segmental 
fracture of tibia and fibula (left), treated 











Figure 2: Patient with 
tibial fracture (left: 
preoperative x-ray) 






Arthrodesis of the knee is performed in cases of advanced destruction of the joint due to 
chronic infection, osteoarthritis or neuropathic arthropathy, where an endoprosthesis 
cannot be implanted or does not improve the joint function. It may also be performed as 
salvage procedure in cases of recurrent periprosthetic joint infection. The ankylosis of the 
knee is usually performed with plates, intramedullary nails or an external fixator (15). 
Arthrodesis of the upper ankle joint is a surgical treatment for arthrosis if symptoms 
progress and the conservative therapy is no longer effective. In patients with upper ankle 
joint osteoarthritis pain, instability and deformity may be addressed with an arthrodesis. 
It is commonly done with screws, which can be placed through an open access or 
arthroscopically. Other surgical options are ankylosis via plates, intramedullary nails, pins 
or external fixator (16).  








Figure 4: Patient with posttraumatic arthrosis of  the ankle treated 













1.1.3 Corrective osteotomy 
Correction of the leg axis may be restored by osteotomy. This procedure is mainly 
indicated for patients with unicompartimental osteoarthritis of the hip or knee due to a 
malposition of the axis. The indication of an osteotomy needs to be strictly evaluated as 
an alternative for the placement of an endoprothesis. The corrective osteotomy is mainly 
realized with plates rarely with intramedullary nails or external fixators (15). 
 




Figure 5: Angular deformity, 
osteotomy for correction of 





Figure 6: Fixation of the osteotomy with 







1.1.4 Distraction osteogenesis 
The technique of distraction is used for reconstruction of bone defects or deformities in 
patients with congenital or posttraumatic defects and in tumor surgery. Surgeries for 
distraction osteogenesis are mainly performed with external fixators, but can also be 
carried out with an intramedullary nail (19). 















Figure 7: Distraction osteogenesis with an intramedullary nail, showing both femurs (left) 
and the left femur (right) of patient number 112 of our cohort 
 
1.1.5 Internal fixation after bone tumor 
Malignant tumors require complete resection and may cause bone defects of variable 
sizes. Different surgical treatments exist to address those bone defects. An option for 
bridging long bone defects is for example the fibula-pro-tibia reconstruction (19). Fibula-
pro-tibia reconstruction, also known as fibula centralization, can be performed as a single-
stage reconstruction technique to bridge the tibial defect and to achieve a functional 
outcome for the limp. The tibial lesion needs to be excised and a proportionate length of 
the fibula including the muscle and vessels is moved medially in the tibial gap. After 
centralization the fibula fragment can be stabilized with a combination of plates, screws 
and wires (20). 





Figure 8: MRI of the lower leg showing an Ewing’s sarcoma (left), x-ray showing a fibula-
pro-tibia reconstruction (right) (20) 
 
1.2 Infections after internal fixation  
Infection after internal fixation is an earnest complication. The presence of an implant and 
the consecutive biofilm formation represent a considerable challenge regarding diagnosis 
and treatment of this specific entity.  
 
 1.2.1 Definition 
In clinical and scientific practice, there was no uniform or standardized definition of 
infection after internal fixation worldwide and in different institutions until a few years ago 
(1). In a systematic review by Metsemakers et al. it was shown, that 70% of the 
randomized controlled trials reporting clinical practice approaches of infections after 
fracture fixation did not provide a description of the used definition (21). By the Centers 




for Disease Control (CDC) guidelines the surgical site infections are classified into 
superficial, deep or organ/space infections, however osteomyelitis is not included (22). 
Bhandari et al. stated that there is not even a consensus when it comes to the definition 
of nonunion (23). 
A widely used definition in Europe is extrapolated from the definition of periprosthetic joint 
infection. According to this classification system of Ochsner et al. (24), infection after 
internal fixation is confirmed if at least one of the following criteria applies: 
• “Abscess with pus discharge following incision 
• Presence of a sinus tract or pus  
• Microbiological detection of the same pathogen in at least two samples (tissue 
samples, sonication fluid) 
• Histological preparations containing a total of more than 20-25 granulocytes in 10 
fields of view at 400x magnification (25).”  
In an expert panel, a recent effort was made to develop a consensus definition. The 
consensus process was designed specifically to address the development of a definition 
for fracture-related infection. They proposed two groups of diagnostic criteria with 
different levels of certainty: confirmatory and suggestive criteria (26). 
Extracted from “Fracture-related infection: a consensus on definition from an international 
expert group” by Metsemakers et al. (26):  
 
Confirmatory criteria for fracture-related infection 
• Sinus tract or wound breakdown 
• purulent drainage or pus at the surgical site  
• cultivation of a pathogen from at least two separate deep tissue samples or the 
implant (including sonication fluid) 




• microorganisms in a histopathological examination of deep tissue 
 
Suggestive criteria for fracture-related infection 
• local or systemic clinical signs: pain, redness, swelling, warmth, fever 
• new-onset of joint effusion 
• wound discharge (persistent, increasing or new-onset) 
• pathological inflammatory markers: erythrocyte sedimentation rate (ESR), white 
blood cell count (WBC), serum C-reactive protein (CRP) persistent high level or 
secondary increase, without other infectious foci identified 
• radiological imaging signs: bone lysis, implant loosening, sequestration, nonunion 
or periosteal bone formation  
• cultivation of a pathogenic organism from a single deep tissue or the implant 
(including sonication fluid) 
 
1.2.2 Epidemiology 
The incidence of infection after internal fixation varies widely and depends on the 
underlying pathology or indication for fixation, the anatomic location, the soft tissue 
involvement and the employed procedural precautions such as antimicrobial prophylaxis. 
Overall about 5% of the primary internal fixation devices become infected (27). Depending 
on the fracture types and the anatomic location the infection rate after fracture fixation 
varies from 1% in closed up to 30% in open fractures (28-31). For osteotomy with internal 
fixation an infection rate of less than 3% is described (32). However, due to hampered 
diagnosis in implant-associated infections owing to the biofilm formation, low grade 
infections are easily missed and the infection rates are probably widely underestimated. 




      1.2.3 Pathogenesis 
1.2.3.1 Biofilm 
The high susceptibility of implanted devices to infection is explained by a local defect of 
host defense, and persistence is mainly caused by formation of a biofilm, which is 
resistant to host defense and antimicrobial agents due to a lack of vascularisation (33). 
The establishment of a biofilm includes initial microbial adherence to the implant surface 
upon the first contact, which is mediated by host-derived adhesins (including fibrinogen, 
fibronectin and collagen). The biofilm then recruits additional planktonic (free-floating) 
organisms and also secretes bacterial products (34). Further development results in 
organized structures with numerous microorganisms surrounded by a self-produced 
matrix (exopolysaccharides, DNA and proteins) (33). The microbes of the biofilm are in a 
slow- or non-growing (stationary) state, which makes them 1,000 times more resistant to 
antimicrobial treatment than their planktonic counterparts (35, 36).  
 
 
Figure 9: Biofilm microorganisms are attached to the implant surface and protected by an 
extracellular matrix, planktonic microorganisms are eradicated by the immune system 
and antibiotics (2)  
 
 




  1.2.3.2 Route of infection 
Colonization of an internal fixation device occurs preoperatively during the initial injury, 
perioperatively during the implantation of the device or postoperatively in case of a 
persistent wound dehiscence (37, 38). A secondary hematogenous infection of the 
osteosynthesis following bacteremia is rare. A prospective study of Murdoch et al. did 
show a 7% infection rate of osteosynthesis in patients with Staphylococcus aureus-
bacteremia (39). The primary infection focus may be located in the pulmonary, 
gastrointestinal or urogenital tract, in the cardiovascular system (heart valves, 
intravascular catheters or cardiac implantable electronic devices), oral cavity or in the skin 
and soft tissue. Furthermore orthopedic implants get infected due to a contiguous 
contamination from an adjacent infection focus affecting the skin, soft tissue or 
intraabdominal/ -pelvic region (40). 
 
  1.2.3.3 Osteomyelitis 
The term osteomyelitis implies that the cortex and the medulla of a bone are infected. 
Periosteal stripping, medullary ischemia and inflammatory cells lead to bone death. 
Those sequesters can either stay trapped in the bone (involucrum) or migrate to the 
surface through a sinus tract. The infection may be silent over years and be reactivated 
at a later stage or persist with constant drainage via fistula for a long period (41). Cierny 
and Mader classified chronic osteomyelitis due to the anatomic types of the disease and 
additionally took into account the physiological status of the patient regarding the capacity 
of the host’s defense (42).  
 





Figure 10: Evolution of bone infection from acute medullary infection to chronic 
osteomyelitis (41) 
 
  1.2.3.4 Microbiology 
The pathogenesis of infection determines the spectrum of pathogens. Mainly 
Staphylococcus aureus (30%) and coagulase-negative staphylococci (22%) are found in 
osteosynthesis-associated infections (43). In cases of infections due to a hematogenous 
spread from a soft tissue infection or an intravascular foreign body Staphylococcus 




species are most common, in secondary infections originating from the pulmonary tract 
streptococci are expected and from abdominal infections gram-negative bacteria and 
enterococci are usually found. When the osteosynthesis-associated infection is caused 
by the invasion of pathogens through the initial trauma, the type of fracture, soft tissue 
damage and environment of the accident is considerably influencing the spectrum of 
pathogens (43). Especially in trauma with severe soft tissue damage gram-negative 
pathogens and mixed infections with anaerobes have to be expected (44). A retrospective 
study including 132 patients showed that 27% of the infected internal fixations were 
caused by more than one pathogen (mixed infections), 30% of the cases had a 
Staphylococcus aureus infection, 22% infections caused by coagulase-negative 
staphylococci, 10% by gram-negative bacilli,  and a minority by other pathogens (45). An 
epidemiologic study revealed a pathogen shift from gram-positive to gram-negative 
strains with high incidence of Pseudomonas aeruginosa and polymicrobial infections in 
sub-/total major traumatic amputations (44). 
Additionally, in terms of treatment options the presence of pathogens causing difficult-to-
treat infections must be considered. Those pathogens are resistant to biofilm active 
antimicrobials and thus eradication of the infected foreign body is not possible (40). 
Pathogens evoking difficult-to-treat infections are rifampin-resistant staphylococci, 
ciprofloxacin-resistant gram-negative pathogens and fungi (e.g. Candida spp.) (8). 
 
1.2.4 Classification  
There are different classification systems for infections after internal fixation (46). With 
regards to the time interval from primary implantation of the fixation device until the 
infection diagnosis, infections are considered as early (less than 2 weeks), delayed (2-10 
weeks) or late infection (more than 10 weeks) (1, 47-49). An early-onset infection is 




usually characterized by prominent local or systemic signs of infection or wound 
dehiscence. It is often caused by high-virulent pathogens such as Staphylococcus aureus 
or gram-negative pathogens. The delayed and late infections are predominantly caused 
by less virulent pathogens, such as coagulase-negative staphylococci (e.g. 
Staphylococcus epidermidis) and Cutibacterium (formerly known as Propionibacterium) 
species. In the course of time the biofilm matures and gets more resistant to antimicrobial 
treatment and host defense (1, 2). Therefore, the infection is considered to be chronic 
after 6 weeks, which has relevant impact on the choice of treatment. Clinically the delayed 
and late infections often present with local signs of infection, pain, compromised 
functionality and present in some cases with a draining fistula. In cases of with nonunion, 
movement-induced pain and functional impairment, an infection with low-virulent 
pathogens should be taken into account (50). Persisting bone instability is a sign for 
delayed and late infections. Even if bone healing had taken place, osteolysis and 
inflammation eventually lead to instability of the osteosynthesis. A chronic osteomyelitis 
may even cause a new bone formation within the medulla or under the elevated 
periosteum producing an involucrum (9, 41).  
According to the anatomic extension, Cierny and Mader classified osteomyelitis in 
medullary, superficial, local and diffuse infections (Figure 11) (42). A different 
classification system categorizes the pathogenesis of the infection into exogenic, 










Figure 11: Anatomic classification of adult 








  1.2.5 Diagnosis 
The diagnosis of an implant-associated infection is made with a synopsis of findings, 
which include patient’s history, clinical presentation, laboratory, imaging studies, 
microbiology and histopathology.  
 
1.2.5.1 Patient’s History and Clinical Presentation 
Reports of antimicrobial therapy prescribed in the early course after the primary fracture 
fixation and performed revision surgeries after index surgery are suggestive for an 
infection of the osteosynthesis although infection was formally not diagnosed at that point. 
The clinical presentation of an osteosynthesis-associated infection varies depending on 
the initial trauma, the type of fracture fixation, the anatomic location, condition of the soft 
tissue, virulence of the pathogen and onset of the infection (5). In anatomic locations with 
thin soft tissue and in early-onset infections with high-virulent pathogens, local signs of 
infection are more common and more prominent. 
In cases of osteomyelitis after plating the complications occurs at the interface between 
plate and bone and between plate and soft tissue. The contact with the surface of the 




plate may lead to devascularized areas, necrotic bone and in the later course to 
sequestration and delayed union/ nonunion. If soft tissue is compromised, a 
subcutaneous plate will cause earlier local sings of infection than a submuscular or 
subfascial plate (2). In cases of infection after intramedullary nailing the inner part of bone 
cortex is affected and will cause impaired fracture healing and nonunion (51, 52). In cases 
of infection after fracture fixation a weaker callus formation is expected (53). Lovati et al. 
showed in experimental studies that Staphylococcus epidermidis inoculation into a 
fracture gap leads to nonunion rates of 83-100% in rats (54). 
Postoperatively after the initial fracture fixation a persistent wound drainage or 
dehiscence is suspicious for infection. Definitive signs of infection are pus drainage or 
draining sinus tract which communicates with the implant, a positive probe-to-implant and 
internal fixation material on view (see Figure 12 and 13) (1, 55). In chronic infections with 
low-virulent pathogens, the clinical presentation is often less prominent. Systemic signs 
of infection such as fever and sepsis are rare. In contrast, patients with acute 
hematogenous infection secondary to a distant infection focus may present with systemic 
signs and sepsis (40). 
 
Figure 12: Patient with a previously open 
tibial fracture, treated with plating, now 
showing a wound breakdown and a 








Figure 13: Patient with a wound breakdown 







1.2.5.2 Laboratory values 
Systemic inflammatory markers, such as serum C- reactive protein (CRP) are widely used 
in the setting of a suspected infection after fracture-fixation. However, due to low 
sensitivity and specificity they are not helpful to exclude or confirm an infection (58). They 
are therefore considered a suggestive criterion for infection and not confirmatory. In 
contrast, the relative changes of the CRP level after internal fixation is a helpful diagnostic 
marker (59, 60). Suggestive for an early-onset infection is a persistent high level of CRP 
or a secondary increase of the CRP level, after an initial decline postoperatively (2). White 
blood cell count, procalcitonin and erythrocyte sedimentation rate are also not sufficiently 
sensitive (3, 61). In patients with chronic infections or a sinus tract, the inflammatory 
markers may be normal (3).  
If the internal fixation is close to an adjacent joint and a septic arthritis is suspected, an 
arthrocentesis is recommended to clarify, if the joint is involved in infection. A leukocyte 
count in synovial fluid of >2000/µl or >70% granulocytes is highly suggestive for an 
infection (with some exceptions such as early postoperative phase, after trauma, in 
patients with underlying rheumatologic disease etc.) (62). 
 




1.2.5.3 Imaging studies 
Imaging studies are helpful to make the diagnosis of an implant-associated infection, 
especially in cases of delayed or late infections (2). Even though conventional x-rays are 
not very sensitive nor specific for bone infections, they are often obtained as an initial 
imaging study to rule out other pathologies, such as tumor and fracture. In subacute or 
chronic stages of osteomyelitis, specific diagnostic signs, like abscesses, sequestrum, 
sinus tract, nonunion and implant loosening can identified (63). 
 
Figure 14: Conventional x-rays showing 
a nonunion of an open tibial fracture 





Computed tomography (CT) imaging with intravenous contrast depicts changes in the 
surrounding soft tissue in addition to the modification in the bone (as described above). 
Furthermore, computed tomography and magnetic resonance imaging (MRI) are helpful 
for treatment planning. In comparison to other imaging studies, magnetic resonance 
shows edema and exudates in the medullary space, changes of the soft tissue or sinus 
tracts (63). An enhancement with gadolinium in magnetic resonance imaging helps to 
differentiate between abscess and cellulitis (64). However, metallic artefacts have a major 
negative impact on image quality of computed tomography and magnetic resonance (2). 




Figure 15: MRI study of a patient with chronic 
osteomyelitis of the femur; signs of infection are 













Nuclear imaging studies have a high sensitivity but a low specificity. They can be used in 
cases of multifocal infections and for patients with metallic hardware in place where the 
infection diagnosis is not confirmed. The different types of nuclear imaging such as 
technetium-99m labeled methylene diphosphonate (Tc-99m MDP), gallium-67 citrate, 
indium-111-labeled WBCs and fluorine-18 fluorodeoxyglucose positron-emission 
tomography computed tomography (FDG-PET CT) all detect early stages of 
musculoskeletal infections before they can be detected in x-rays (63). The FDG-PET CT 
is a relatively new tool in this field and is expected to be able to detect biofilms and 
antimicrobial peptides in the future (65). However, due to interference with the normal 




healing process after fracture and fixation surgery, it may be false positive at an early 
stage. 
Sonography is a useful method to diagnose abscesses and to estimate their extent. 
Supplementary ultrasound is helpful for performing a diagnostic aspiration (66). 
 
1.2.5.4 Microbiology and histopathology analysis 
Knowledge of the causing pathogen is essential to confirm the diagnosis and to guide the 
antimicrobial treatment. At least three to five intraoperative tissue samples should be 
harvested to increase the detection rate of infecting microorganism. Superficial swabs 
from an open wound or a sinus tract are not recommended, as they usually show normal 
skin microbiome, do not correlate with the pathogens found in the deep tissue and are, 
therefore not representative. For discrimination between contaminant and real pathogen 
in case of a typical skin microbiome organism, at least two specimens yielding the same 
pathogen are required to confirm infection. For virulent species such as Staphylococcus 
aureus and Escherichia coli one positive tissue sample is sufficient (67). It is of utmost 
importance to take the specimens from representative areas with the most inflammatory 
changes, i.e. the nonunion zone or the interface between implant and bone (2). 
Antimicrobial therapy should preferably be withheld or discontinued at least two weeks 
prior to taking the tissue samples (68). Prolonged culture incubation up to 14 days is 
recommended in order to detect slowly growing pathogens such as Cutibacterium spp., 
usually involved in implant-associated infections (69). However, the prolonged incubation 
bears the risk of culturing microbiological contaminants (1). 
As bacteria reside in high density in the biofilm in implant-associated infections, novel 
diagnostic methods to dislodge the biofilm and embedded bacteria from the implant were 
developed. A well-established technique is sonication, which has been shown to improve 




the pathogen detection rate in implant-associated infections in different medical fields (70-
72). Especially in cases of painful internal-fracture fixation implants with no clinical signs 
of infection, sonication is a useful tool to support diagnostic and treatment decisions (73).  
The polymerase chain reaction (PCR) is an additional method to detect pathogens 
causing infection. In studies for prosthetic infections it could be shown that PCR is 
especially useful in cases with negative cultures and in patients undergoing antimicrobial 
therapy (74-76). The limitations to PCR are a high risk of false positive results and that it 
does not provide comprehensive information about the susceptibility to antibiotics (77-
79). 
For a histopathologic diagnosis, multiple biopsies of different sites are needed. Ochsner 
et at. showed that there are typical histological characteristics found in patients with 
osteosynthesis-associated infections (80). Bone necrosis and sequestration are a regular 
finding and additionally helpful for classifying the duration of the infection. A centralization 
of bone necrosis and sequester is a sign for a chronic infection. Other signs which are 
indicative for infection are abscess membranes and periosteal new bone formations. The 
surrounding soft tissue may also show signs of infection. Extensive granulocytes are 
indicative for acute infections, plasma cells and lymphocytes are typical for chronic 
infections (80). A recent study by Morgenstern et al. showed that histopathological 
samples with more than five neutrophil polymorph counts per high power field have a 
sensitivity of 80% and a specificity of 100% regarding the diagnosis of fracture- related 
infections in patients with nonunion (81). The histopathology results can also exclude 
other diagnosis, such as a malignancy (50).  
 




1.2.6 Therapy  
Aim of the therapy of osteosynthesis-associated infections is the adequate healing of the 
bone and to prevent osteomyelitis and chronification of infection (2). If the fixation device 
is only needed until the bone healed, suppression of the infection until removal of the 
implant may be a feasible alternative to the eradication of implant-associated infections 
(1). The key to success in implant-associated infections is a concerted treatment concept 
consisting of surgical debridement (if applicable with removal or exchange of the implant) 
followed by an antimicrobial therapy. 
 
1.2.6.1 Surgical Therapy 
The decision on surgical therapy is based on the consolidation of the bone (6). If the 
infection occurs after the bone is well consolidated, the surgical procedure of choice is 
debridement and removal of the implant, if in place (3). If the bone is not consolidated 
yet, the surgical treatment algorithm differentiates between early-onset and late-onset 
infections based on the age of the biofilm (see Figure 16). In an early-onset infection the 
internal fixation device can be retained and a sound debridement should be performed 
(3). This treatment is only possible if the implant is stable and the reduction is adequate, 
the soft tissue is in good condition (i.e. absence of an abscess and sinus tract) and the 
microorganisms are susceptible to biofilm-active antimicrobial therapy (4). In case of a 
late-onset infection the implant needs to be exchanged, either in a one-stage or two-stage 
procedure. A one-stage surgical procedure is possible if the soft tissue is in a good 
condition, there is no sinus tract or extensive bone defect and the causing pathogen is 
preferably known (2, 5). A two-stage surgical procedure needs to be considered, if there 
is a major soft tissue defect or in the presence of a sinus tract. The bridging stabilization 




of the bone during the implant-free interval can be managed with an external fixator, (e-
g- Ilizarov-fixator), a spacer or a cast. 
 
 
Figure 16: Treatment Algorithm, extracted from “Pocket Guide to Diagnosis and 
Treatment of implant-associated infections after fracture fixation”, PRO-IMPLANT 
Foundation, N. Renz, A. Trampuz” 
 
Regarding the soft tissue defect, a skin grafting might be necessary. If the infection is 
difficult to treat, i.e. caused by a pathogen which is not susceptible to biofilm-active 
antibiotics (see above), a two-stage surgical procedure is recommended, as the infection 
cannot be eradicated in presence of an implant. The re-osteosynthesis is then performed 




after an implant-free interval in which the pathogen will be definitely eradicated (6). In the 
first stage surgery all implants and dead tissue (including sequestrum and necrosis) need 
to be removed (1, 82). In large bone defects, antibiotic loaded cement or bone substitutes 
may be placed, for a local antimicrobial treatment and to enable Masquelet technique in 
the second surgery (82). Complicating factors for the surgical treatment are 
multifragmentary fractures and involvement of a joint (6). Negative pressure wound 
therapy (NPWT) is not a preferred treatment for infection. It may be used to address a 
challenging soft-tissue condition only (83, 84). In case of using a vacuum-assisted-
closure-therapy (VAC), the bone and the implant need to be covered by tissue and should 
never be in direct contact with the VAC-system. Otherwise the risk of superinfection 
caused by multidrug-resistant pathogens, additional colonization with gram-negative 
bacteria (including Pseudomonas aeruginosa) or fungi is increased (6).  
 
1.2.6.2 Antimicrobial Therapy 
The antimicrobial therapy needs to be coordinated with the surgical treatment regimen. A 
considerable reduction of the bacterial count through a meticulous surgical debridement 
a prerequisite for a successful antimicrobial treatment (7). Antimicrobial substances with 
a bactericidal effect, good bone penetration, high bioavailability and -in case of implant 
retention- with biofilm activity, should be used. Only in cases of resistant pathogens 
bacteriostatic drugs, such as Clindamycin or Linezolid represent an alternative (6) (see 
Table 3). Empirical antibiotic therapy usually is ampicillin/sulbactam 3 x 3 g i.v. or 
amoxicillin/clavulanate 3 x 1.2 g i.v. In cases of Gustilo type III open fracture or sinus tract 
piperacillin/tazobactam 3 x 4.5 g i.v is preferable, to also cover the gram-negative 
pathogens (6). Once the microbiology results are available the treatment can be changed 




to pathogen specific therapy (see Table 1 and 2). The systemic antimicrobial treatment 
can be combined with a local antibiotic therapy.  
 





▪ Flucloxacillin 4 x 2 g i.v.  
For two weeks followed by 
▪ Rifampin 2 x 450 mg p.o. plus 
▪ Levofloxacin 2 x 500 mg p.o. or  
▪ Cotrimoxazole 3 x 960 mg p.o. or  
▪ Doxycyclin 2 x 100 mg p.o. 
Oxacillin-/ methicillin- 
resistant 
▪ Daptomycin once 8mg/kg body weight i.v. or 
▪ Vancomycin 2 x 1 g i.v.  
For two weeks followed by oral rifampin- combination 
(see above)  
Rifampin-resistant Intravenous therapy for two weeks (see above) plus, 
long-term suppression for ≥ 1 year 
Streptococci spp. ▪ Penicillin G 4 x 5 Mio. I.U. i.v. or 
▪ Ceftriaxone 1 x 2 g i.v. 
For two to four weeks, followed by 
▪ Amoxicillin 3 x 1000 mg p.o. or 
▪ Doxycycline 2 x 100 mg p.o. 
 





Penicillin-susceptible ▪ Ampicillin 4 x 2 g i.v. plus  
▪ Gentamicin 1 x 120 mg i.v. or 
▪ Ceftriaxon 2 x 2 g i.v. (if E. faecalis) 
For two to three weeks, followed by 
▪ Amoxicillin 3 x 1000 mg p.o. 
Penicillin-resistant ▪ Vancomycin 2 x 1 g i.v. or 
▪ Daptomycin 1 x 10 mg/kg body weight i.v. plus  
▪ Gentamicin 1 x 120 mg i.v. 
For two to four weeks followed by 
▪ Linezolid (maximal four weeks) 2 x 600 mg p.o. 
Vancomycin-resistant 
(VRE)  




(E. coli, Klebsiella, 
Enterobacter etc.) 





▪ Piperacillin/tazobactam 3 x 4.5 g i.v. or 
▪ Meropenem 3 x 1 g i.v. or 
▪ Ceftazidim 3 x 2 g i.v. plus 
▪ Tobramycin 1 x 300 mg i.v. 
For two to three weeks, followed by 
▪ Ciprofloxacin 2 x 750 mg p.o. 
Ciprofloxacin-resistant Depending on the sensitivity: 
▪ Meropenem 3 x 1 g 




▪ Colistin 3 x 3 Mio. I.U. and/ or 
▪ Fosfomycin 3 x 5 g i.v.  






▪ Penicillin G 4 x 5 Mio.I.U. i.v. or 
▪ Ceftriaxon 1 x 2 g i.v. 
For two weeks, followed by 
▪ Rifampin 2 x 450 mg p.o. plus 
▪ Levofloxacin 2 x 500 mg p.o. or 
▪ Amoxicillin 3 x 1000 mg p.o. 
Gram-negative 
(Bacteroides) 
▪ Ampicillin/sulbactam 3 x 3 g i.v. 
For two weeks, followed by 
▪ Metronidazole 3 x 400 or 500 mg p.o.  
Candida spp. 
Fluconazole-susceptible ▪ Caspofungin 1x 70 mg i.v. 
for two weeks, followed by  
▪ Fluconazole once 400 mg p.o. 
(suppression for ≥1 year) 
Fluconazole-resistant Individual (e.g. Voriconazol 2 x 200 mg p.o.)  
Removal of implant or long- term suppression 
Negative microbiology 
result (culture-negative) 
▪ Ampicillin/sulbactam 3 x 3 g i.v. 
for two weeks followed by  
▪ Rifampin 2 x 450 mg p.o. plus 
▪ Levofloxacin 2 x 500 mg p.o. 
 




Usually the antimicrobial therapy is given over a time period of 12 weeks if an implant is 
involved in the infection (2, 85). In case of a consolidated fracture and performed bone 
debridement and implant removal, the treatment duration can be shortened to 6 weeks. 
The intravenous treatment allows for a high tissue concentration and therewith a quick 
reduction of bacterial count. The oral treatment should only be switched to oral 
formulations, if the wound is dry and the CRP level is declining (6).  
Another concept of antimicrobial treatment relies on suppression of the infection until 
fracture healing and implant removal (see Table 2). This is not only an option for 
multifragment fractures but also for difficult-to-treat infections (6). As long as the implant 
is still in place, a discontinuation of the suppressive treatment may lead to a recurrence 
of the infection (8). 
 
Table 2: Suppressive therapy during implant free interval or after removal of the implant 
(6) 
Pathogen Substance 
Staphylococci Cotrimoxazole or doxycycline or clindamycin 
Streptococci Amoxicillin or clindamycin or doxycycline 
Enterococci Amoxicillin (or linezolid) 
Anaerobes (gram-positive) Clindamycin or amoxicillin 
Anaerobes (gram-negative) Metronidazole or clindamycin 
Gram-negative pathogens Ciprofloxacin or cotrimoxazole 
 
1.2.7 Prevention 
Perioperative antibiotic prophylaxis reduces the risk of postoperative infections and is 
therefore well established in orthopedic surgery (86). A single dose of a cephalosporine 




30-60 minutes prior to skin incision is most efficient and needs to be repeated if the 
procedural time is longer than 3 hours or if the blood loss exceeds 1500 ml. In cases of a 
severe cephalosporine allergy, vancomycin can be used instead. If there is a severe soft 
tissue defect, the antibiotic therapy needs to be extended according to the expected 
pathogens. In case of a skin colonization with methicillin resistant Staphylococcus aureus 
(MRSA) or preceding antibiotic therapy, vancomycin should be given additionally to a 
cephalosporine (6). For a patient with a Gustilo type III open fracture a combination of 
ampicillin/sulbactam or piperacillin/tazobactam should be given for five further days to 
prevent transition from colonization to infection (preemptive therapy) (87, 88). There was 
no benefit shown for antibiotic prophylaxis in surgeries of implant removal or in surgery 
with implantation of screws or pins (88). 
 
Table 3: Perioperative antibiotic prophylaxis and preemptive therapy (6) 





Cefazolin 2 g i.v. or 
Cefuroxim 1.5 g i.v. 
Vancomycin 1 g i.v. Single shot 
Open fracture, 
type I and II 
Cefazolin 2 g i.v. or 
Cefuroxim 1.5 g i.v. 
Vancomycin 1 g i.v. Single shot, 
max. 24 hrs. 
Open fracture, 
type III 
Ampicillin/sulbactam 3 g 
i.v. 8 hourly or  
Piperacillin/tazobactam 
4.5 g i.v. 8 hourly 
Vancomycin 1 g i.v. 12 
hourly plus ciprofloxacin 
400 mg i.v. 12 hourly 
5 days 
 




1.3 Aim of this study 
Aim of this study is to analyze epidemiological, clinical and diagnostic characteristics of 
infections of long bones after internal fixation. Furthermore, it aims at assessing treatment 
approaches and outcome of these infections with a special focus on the impact of the 
current standardized treatment of the interdisciplinary infectious diseases and surgical 
team at the Charité Universitätsmedizin.  




2.1 Study Design 
This retrospective cohort study was conducted in the orthopedics and traumatology 
facility at Charité Universitätsmedizin Berlin, a tertiary healthcare center providing 
advanced specialty care to a population of four million inhabitants. Patients with infections 
after internal-fixation of a long bone were identified in the electronic medical record 
system based on the ICD-diagnosis M.86 (Osteomyelitis) and the ICD- diagnosis T86.4 
(Infection and inflammatory reaction due to internal fixation device). In addition, the 
institutional database of patients with musculoskeletal infections was screened. The study 
protocol was reviewed and approved by the institutional ethics committee and was 
performed in accordance with the Declaration of Helsinki. This study was conducted as 
subproject of the institutional implant infection cohort and the need for informed consent 
was waived (application number EA2/132/15).  
The patients’ data was collected from the electronical records using a standardized 
protocol and was classified in a case report form (CRF) specifically designed for this 
purpose (see Figure 17). 
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Fixation device- associated infection - Charité university hospital Berlin 
retrospective study (2010 - 2017) 
Patient data:                                                                                                                             No.:_____ 
Last name, first name: ____________________________________    DOB: ______________  
Sex:  M    F      Age (Admission): ______   BMI: _________   ASA: _____ 
Coexisting medical conditions:   DM    RF    HF    MA    Immunosupp.    Immune Deficieny 
Infected bones: 
Infected joints: 
 humerus    radius    ulna    femur    tibia    fibula     
 septic arthritis:    shoulder    elbow    wrist    hip    knee    ankle    
Date of injury:__________________  Fracture:  upper arm   forearm   thigh   lower leg   ankle 
Cause:traffic acci.  fall  path.f.   Type : closed  open:Grade I  II  III   polytrauma: no  yes   
Prior operations of the infected bone: 
 1. surgery (date):_______________ 
diagnosis:_______________________________ 
procedure:_______________________________ 
 debridement   lavage   VAC 
 removal of material:  total    partial________ 
 material:_______________________________ 
 other:_________________________________ 
 2. surgery (date):______________ 
diagnosis:_______________________________ 
procedure:_______________________________ 
 debridement   lavage   VAC 
 removal of material:  total    partial________ 
 material:_______________________________ 
 other:_________________________________ 
 3. surgery (date):________________ 
diagnosis:_______________________________ 
procedure:_______________________________ 
 debridement   lavage   VAC 
 removal of material:  total    partial________ 
 material:_______________________________ 
 4. surgery (date):_____________ 
diagnosis:_______________________________ 
procedure:_______________________________ 
 debridement   lavage   VAC 
 removal of material:  total    partial________ 
 material:_______________________________ 
 5. surgery (date):________________ 
diagnosis:_______________________________ 
procedure:_______________________________ 
 debridement   lavage   VAC 
 removal of material:  total    partial________ 
 material:_______________________________ 
 6. surgery (date):_____________ 
diagnosis:_______________________________ 
procedure:_______________________________ 
 debridement   lavage   VAC 
 removal of material:  total    partial________ 
 material:_______________________________ 
Prior microbiology: date: ___________  germ: ___________________________________________ 
Preoperative laboratory: date: ___________  CRP (mg/dl): _________ 
Signs/symptoms: Fever:y/n pain red warm swelling secretion fistula material vis woundd 
Current hospitalization:        ER/  Polyclinic/  transfer 
1.stay:__________________,____days; diagnosis:_________________________________________ 
Radiology (X-ray, MRI, CT): Suggestive signs of infection: 
 X-ray ________ diagnosis_____________________________   no specific signs for osteomyelitis  
    sequestrum   soft tissue oedema   fistula   implant loosening   delayed union   non- union 
    other: _________________________________________________________________________ 
 MRI ________ diagnosis: _____________________________   no specific signs for osteomyelitis  
    sequestrum   soft tissue oedema   fistula   implant loosening   delayed union   non- union  
    other: _________________________________________________________________________ 
 CT ________ diagnosis:_______________________________   no specific signs for osteomyelitis  
    sequestrum   soft tissue oedema   fistula   implant loosening   delayed union    non- union  
    other: _________________________________________________________________________ 
 other: __________________________________________________________________________ 
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Surgeries:   pus visible     sequestrum visible 
1. surgery: ___________   Diagnosis: ________________________________   
Procedure: _______________  debridement  fistula excision  intramedullary drill  sequestrectomy 
arthrodesis  amputation  bone grafting.:________________  skin grafting:_____________  VAC 
material:  Fixateur externe    Ilizarow fixateur    ORIF ( intramedullary nail   plate osteosynthesis)  
                Pins   screws   PMMA ( chains   Spacer)    
removal of material   total   partially   _________________________________________________ 
Microbiology: intraoperative specimen positive:___ total:___ 
germ:_____________________________ pos.:__; DTT- Resistenz:___________________________ 
germ:_____________________________ pos.:__; DTT- Resistenz:___________________________ 
germ:_____________________________ pos.:__; DTT- Resistenz:___________________________ 
Sonication:  ND /  neg.  pos. :germ:______________________________  ____ KBE /ml    n. A. 
Pathology: diagnosis:__________________________________________  no specific signs for OM 
                     sequester     inflammation: _______________________________________________   
2. surgery: ___________   Diagnosis: ________________________________   
Procedure: _______________  debridement  fistula excision  intramedullary drill  sequestrectomy 
arthrodesis  amputation  bone grafting.:________________  skin grafting:_____________  VAC 
material:  Fixateur externe    Ilizarow fixateur    ORIF ( intramedullary nail   plate osteosynthesis)  
                PMMA ( chains   Spacer)    
removal of material   total   partially   _________________________________________________ 
Microbiology: intraoperative specimen positive:___ total:___ 
germ:_____________________________ pos.:__; DTT- Resistenz:___________________________ 
germ:_____________________________ pos.:__; DTT- Resistenz:___________________________ 
germ:_____________________________ pos.:__; DTT- Resistenz:___________________________ 
Sonication:  ND /  neg.  pos. :germ:______________________________  ____ KBE /ml    n. A 
Pathology: diagnosis:__________________________________________  no specific signs for OM 
                     sequester     inflammation: _______________________________________________    
3. surgery: ___________  Diagnosis: ________________________________  
Procedure: _______________  debridement  fistula excision  intramedullary drill  sequestrectomy 
arthrodesis  amputation  bone grafting.:________________  skin grafting:_____________  VAC 
material:  Fixateur externe    Ilizarow fixateur    ORIF ( intramedullary nail   plate osteosynthesis)  
               Pins   Screws   PMMA ( chains   Spacer)    
removal of material   total   partially   _________________________________________________ 
Microbiology: intraoperative specimen positive:___ total:___ 
germ:_____________________________ pos.:__; germ:______________________________ pos.:__ 
germ:_____________________________ pos.:__; germ:______________________________ pos.:__ 
germ:_____________________________ pos.:__; germ:______________________________ pos.:__ 
Sonication:  ND /  neg.  pos. :germ:______________________________  ____ KBE /ml    n. A 
Pathology: diagnosis:__________________________________________  no specific signs for OM 
                     sequester     inflammation: _______________________________________________    
Antibiotic therapy (>48h): Application Dates Days Weeks 
  i.v.    p.o.    
  i.v.    p.o.    
  i.v.    p.o.    
  i.v.    p.o.    
  i.v.    p.o.    
Figure 17: Case report form 
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2.2 Study Population 
We included all consecutive patients ≥ 18 years of age from January 1, 2010 to November 
17, 2017, who were treated at our institution for infection of a long bone after internal 
fixation due to a fracture, an osteotomy or an arthrodesis and who fulfilled the inclusion 
criteria (see below). It was not mandatory that the implant was still in place at time of 
admission to our institution.  
Exclusion criteria were osteomyelitis of hematogenous origin or secondary to vascular 
origin, osteomyelitis of the pelvis, head, spine, hands or feet, presence of joint prosthesis 
in the anatomic site of the infection. In addition, patients with infections limited to the soft 
tissue and with incomplete dataset were excluded from the analysis. 
 
2.3 Definitions 
2.3.1 Definition of infection after internal fixation 
Infection after internal fixation of a long bone was confirmed, if the patient presented with 
clinical symptoms and at least one of the following criteria applied:  
• intraoperatively visible purulence, sequestrum or sinus tract 
• positive microbiology: significant growth of a microorganism (definition see below)  
• acute or chronic inflammation in intra-operative tissue histopathology. 
 
2.3.2 Significant microbiology results 
Specimen were considered representative if the tissue or deep swab was obtained 
intraoperatively. We excluded samples from superficial or fistula swab and microbiology 
results from drainage systems from our analysis. If the detected pathogen was highly 
virulent one positive tissue culture and any growth in the sonication was sufficient. For 
low virulent pathogens more than one tissue culture had to grow the identical pathogen 
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and only sonication results showing more than 50 colony forming units (CFU)/ml were 
considered significant. Otherwise, the result was judged as contamination. 
 
2.3.3  Adequate antimicrobial treatment 
The antimicrobial treatment was considered as adequate if the criteria of the current 
standardized comprehensive treatment algorithm as described in 1.2.6 were fulfilled. This 
means the susceptibility testing considered, the type of application regarding 
bioavailability and the duration of the therapy had to be individually matched for each 
patient and the pathogens causing the infection. Furthermore, an adequate antimicrobial 
treatment needed to be adapted according to the surgical treatment, e.g. retention or 
removal of the implant. In case of retention of the implant, the antimicrobial substance 
needed to be biofilm-active. 
 
2.3.4 Outcome definitions 
Failure was defined as a recurrent, persistent, or new infection caused by another 
pathogen in the clinical course. A recurrent, persistent, or new infection was diagnosed 
with microbiological results, tissue histopathology and clinical presentation such as 
implant on view, wound dehiscence and sinus tract at the surgical site.  
Infection success was defined as infection-status without microbiological, 
histopathological nor clinical signs of infection at time of follow-up.  
Functional failure was diagnosed, if functional impairment such as persistent nonunion 
was present, amputation of the limb or resection arthroplasty (Girdlestone situation) was 
performed.  
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2.4 Data collection 
The following patient’s data were collected in a case report form (Figure 17): 
Demographic information including age, sex, height, weight, BMI, ASA- classification, 
coexisting- medical conditions such as, diabetes mellitus type 1 and 2, chronic renal 
failure with creatinine level >220 µmol/l [> 2.5 mg/dl], active malignancy, 
immunosuppression [HIV infection or use of >25 mg prednisone-equivalent/day or other 
immunosuppressive medication in the preceding month], exposure to radiotherapy or 
chemotherapy, hepatic failure (Child-Pugh B or C) were collected. Documented was the 
anatomic side of the infection and if in addition to the long bone a joint was infected as 
well. Information about a fracture and prior surgeries to the infected bone were recorded. 
If the patient had growth of a microorganism in >1 intraoperative tissue from a surgery 
prior to the actual infection episode we captured that information. At time of admission to 
our institution signs and symptoms for a local infection such as pain, redness, excess 
heat, swelling, secretion, sinus tract, visible material and wound dehiscence and signs for 
a systemic infection such as fever and increased serum level of C-reactive protein (CRP) 
were noted. Preoperative radiographic findings such as loosening of the implant, 
nonunion (at > 6 months after fracture fixation), delayed union (at 4-6 months after 
fracture fixation), sequestrum, soft tissue edema and sinus tract were recorded. The type 
of surgical therapy and the intraoperative aspect (pus or sequestrum) were noted. The 
results from the tissue cultures, implant sonication and results of pathology were recorded 
for all patients. Data on type and duration of an antimicrobial was collected. 
 
2.4.1 Follow-up evaluation 
The follow-up was ascertained with the computerized medical charting system. A failure 
or success of the therapy was evaluated with clinical findings, radiological imaging, 
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surgical reports, tissue cultures, sonication results and intraoperative tissue 
histopathology, according to the aforementioned outcome definitions. 
 
2.5 Implementation of a standardized comprehensive treatment 
concept 
In the year 2013, a standardized interdisciplinary treatment was introduced in our 
institution. The above described treatment algorithm of surgical and antimicrobial therapy 
(1.2.6) was adjusted for each patient individually based on the present clinical and 
microbiological features. A dedicated interdisciplinary team consisting of internal 
medicine and infectious diseases specialists and traumatologists was responsible for the 
patients treated for infections of the musculoskeletal system. Before 2013, patients were 
treated at the treating traumatologists decision without standardized concept and without 
collaboration of internal medicine or infectious disease specialists. 
 
2.6 Statistical analysis 
For comparison of categorical variables Fisher’s exact test was applied. The probability 
of infection- free survival and the respective 95% confidence intervals (CI) were estimated 
using the Kaplan-Meier survival method. Survival curves between groups were compared 
by the Log-rank Mantel-Cox test. A univariate analysis was used to determine the 
predictors of treatment failure, followed by a multiple logistic regression model for 
significant predictors in the univariate analysis. A two-sided P value of <0.05 was 
considered significant. For statistical analyses, the program package R (version 3.1.3.) 
and the software Prism (version 7.03; GraphPad, La Jolla, CA, USA) were used. 





Hundred twenty-seven patients with device-associated infection after internal fixation of 
long bones met the criteria for inclusion. Based on the type of the first internal fixation 
device patients were stratified into two groups. The first group contained all patients, who 
received an intramedullary nail for internal fixation. The second group included all 
patients, in whom extramedullary internal fixation devices such as screws, plates, pins or 
a combination of them were used for bone fixation. 
 
3.1.  Patient Characteristics 
The cohort consisted of 89 male (70%) and 38 female (30%) patients with an age ranging 
from 19 to 89 years and a median of 53 years. The median body mass index was 26.5 
kg/m² with a range from 18.4 to 55.6 kg/m². The ASA physical status classification ranged 
from 1 to 4 (median 2). Most patients were otherwise healthy, only a minority of patients 
had coexisting medical conditions such as diabetes mellitus in 14%, active malignancy in 
6%, immune deficiency in 3%, renal failure in 2% and hepatic failure in 1% of the cases. 
The patient characteristics were similar in both groups (see Table 4). 
 










Sex, male 89 (70) 35 (47) 54 (68) 0.431 
Age, median (range) - 
years 
53 (19-89) 53 (19-89) 53 (19-86) 0.352 










26.5 (18.4-55.6) 0.201 
ASA, median (range) 2 (1-4) 2 (1-4) 2 (1-4) 0.617 
Comorbidities 
    
Diabetes mellitus 18 (14) 7 (15) 11 (14) 1.000 
Malignancy 8 (6) 2 (4) 6 (8) 0.709 
Immune deficiency 1 4 (3) - 4 (5) 0.296 
Renal failure 3 (2) - 2 (4) 0.295 
Hepatic failure 1 (1) 1 (2) - 0.370 
NOTE. Data are no. (%) of episodes, if not indicated otherwise 
1 Among them 2 patients with immunosuppression due to kidney-transplantation, 2 
patients with HIV infection 
 
3.2 Baseline characteristics of the infection site 
The baseline characteristics of the index surgeries and the implant history are 
summarized in Table 5. In 111 cases (87%) the lower extremity was affected and in 16 
cases (13%) the upper extremity was involved. The main cause of internal fixation was 
fracture (115 patients). Significantly more open factures were reported in the group with 
intramedullary fixation devices than with extramedullary fixation devices (56% vs. 22%, p 
<0.001). Among all fractures, 38 out of 78 (49%) were caused by a fall, 26 (33%) by traffic 
accidents, 6 (8%) through other accidents, 5 (6%) due to a bomb explosion or bullet injury 
and 4 (5%) were pathological fractures due to bone metastases. In 18 cases (26%) the 
patient experienced a polytrauma. Four patients received internal fixation to perform 
arthrodesis, 3 patients to perform corrective osteotomy, 2 patients for distraction 
osteogenesis and 2 patients to bridge bone defects because of bone tumors. In most 




cases (n=110, 85%), the initial stabilization of the bone was carried out with an internal 
fixation. In 25 cases, cultures from fixation surgery were positive at the index surgery, 
68% of them were monomicrobial and 32% polymicrobial. The clinical consequence of 
the positive cultures is unknown. Of 23 patients we do not have any information about 
revision surgeries after the implementation of the internal fixation until the diagnosis of an 
infection. Of the 104 patients who underwent revision surgeries of the bone at the implant 
site, in average two surgeries were done (range from 1 to 11). 
 











    
Lower extremity 111 (87) 46 (98) 65 (81) 0.005 
Femur  34 21 13 
 
Tibia 62 19 43 
 
Fibula 2 0 2 
 
Femur and tibia 1 0 1 
 
Tibia and fibula 12 6 6 
 
Upper extremity 16 (13) 1 (2) 15 (19) 0.005 
Humerus 9 1 8 
 
Radius 4 0 4 
 
Ulna 3 0 3 
 
Cause for fixation 
    
No fracture 1 12 (9) 4 (9) 8 (10) 1.000 




Fracture 115 (91) 43 (91) 72 (90) 1.000 
Open  40 (35) 24 (56) 16 (22) <0.001 
Closed  33 (29) 10 (23) 23 (32) 0.396 
Not classified 42 (37) 9 (21) 33 (46) 0.009 
Cause of fracture 
    
Fall 38/78 (49) 9/33 (27) 29/45 (64) 0.001 
Traffic accident 26/78 (33) 18/33 (55) 8/45 (18) 0.001 
Other accidents 
(e.g. sporting) 
6/78 (8) 3/33 (9) 2/45 (4) 0.645 
Bullet wound, bomb 
explosion 
5/78 (6) 2/33 (6) 3/45 (7) 1.000 
Pathological 
fracture 2 
4/78 (5) 1/33 (3) 3/45 (7) 0.634 
Polytrauma 18/69 (26) 8/26 (31) 11/36 (31) 1.000 
Initial external fixation 27/110 (25) 8/39 (21) 19/71 (27) 0.497 
Positive microbiology at 
index surgery 
25/45 (55) 7/17 (41) 18/28 (64) 0.216 
Monomicrobial 17 (68) 3 (43) 14 (78) 0.156 
Polymicrobial 8 (32) 4 (57) 4 (22) 0.156 
NOTE. Date are no. (%) of episodes, if not indicated otherwise 
1 Among them 4 cases with arthrodesis, 3 cases with corrective osteotomy, 2 cases with 
distraction osteogenesis; 2 among them 2 cases with bone tumors (one Ewing's sarcoma, 
one osteosarcoma) and 2 cases with bone metastases due to renal cell carcinoma 
 




 3.3 Infection characteristics 
Clinical characteristics of infections after fracture fixation are shown in Table 6. On 
admission to our hospital, in 96 patients (76%) the implant was still in place and implant-
associated infections were present. In the remaining 31 patients, predominantly chronic 
osteomyelitis was diagnosed. The median time from implantation of the internal fixation 
until the onset of the infection was 10.9 months (range from 0.2 to 618.8 months). Notably, 
infections after extramedullary fixation occurred considerably earlier than those after 
intramedullary fixation (i.e. after 7.0 months versus 24.9 months, p=0.027). Acute 
infection occurring within 6 weeks after fixation was reported in 21 of 125 patients (17%), 
104 of 125 (83%) were late-onset infections. The predominant clinical feature of infection 
was local signs such as erythema, excess heat, swelling, wound dehiscence or sinus tract 
and was noted in 96 patients (75%). Whereas sinus tracts were more common in 
infections after intramedullary fixation, wound dehiscence and material on view was 
documented predominantly in infections after extramedullary fixation. Four patients (3%) 
presented with fever and 54 (43%) complained of pain. In 39 cases (31%) a concomitant 
septic arthritis was diagnosed, mostly in the ankle (13 patients), hip (10 patients) and 
knee (9 patients). At admission 64 patients (58%) presented with an elevated CRP (>10 
mg/l). The median CRP was 15.4 mg/l with a range of 0.3 to 334.5 mg/l. Radiological 
imaging showed nonunion in 53 cases (43%), a loose implant in 22 (23%), sequestration 
in 4 (3%) and other signs such as edema, sinus tract, chronic osteomyelitis and abscess 
in 11 cases (9%). 
Eighty-six cases (68%) presented with a monomicrobial infection, 19 (15%) with a mixed 
infection and in 21 cases (17%) all examined samples were culture-negative. In 28 
patients (48%) the pathology was positive for an implant-associated infection. The 
median duration of the hospital stay was 15 days with a range of 3 to 96 days. 














Implant involved 96 (76) 26 (62) 67 (84) 0.010 
Time from implant to 
onset of infection, 
median (range) – 
months 
10.9 (0.2 – 
618.8) 
24.9 (0.5-618.8) 7.0 (0.2-361.7) 0.027 
Acute infection 
(≤6 weeks) 
21/125 (17) 5/45 (11) 15/78 (19) 0.314 
Chronic infection  
(>6 weeks) 
104/125 (83) 40/45 (89) 63/78 (81) 0.314 
Clinical findings 
    
Fever 5 (4) 4 (9) 1 (1) 0.062 
Pain 54 (43) 24 (51) 30 (38) 0.143 
Local signs of infection 1 96 (75) 37 (79) 59 (74) 0.669 
Sinus tract 46 (36) 23 (49) 23 (29) 0.035 
Wound dehiscence 42 (33) 10 (21) 32 (40) 0.033 
Material on view 6 (5) 1 (2) 5 (6) 0.412 
Concomitant septic 
arthritis 
39 (31) 12 (26) 27 (34) 0.426 
Ankle 13 4 9  
Hip 10 7 3  
Knee 9 1 8  




Shoulder 3 0 3  
Elbow 2 0 2  
Wrist 2 0 2  




13.9 (0.7-255.7) 14.8 (0.3-334.5) 0.363 
CRP >10mg/l 64/113 (58) 27/45 (60) 37/68 (54) 0.568 
Radiology  
    
Nonunion 53/122 (43) 18/45 (40) 35/77 (45) 0.576 
Loose implant 22/96 (23) 8/29 (28) 14/67 (21) 1.000 
Sequestrum 4/122 (3) 1/45 (2) 3/77 (4) 1.000 
Other 2 11/122 (9) 4/45 (9) 7/77 (9) 1.000 
Microbiology 
    
Culture-positive 105 (83) 38 (81) 67 (84) 0.809 
      Monomicrobial 86/126 (68) 31 (64) 55/79 (70) 0.558 
      Polymicrobial 19/126 (15) 7 (15) 12/79 (15) 1.000 
Culture-negative 21/126 (17) 9 (19) 12/79 (15) 0.624 
Positive histopathology 28/50 (56) 12/19 (63) 16/31 (52) 0.560 
Hospital stay in days, 
median (range) 
15 (3-96) 15 (3-80) 15 (4-96) 0.764 
NOTE. Data are no. (%) of episodes, if not indicated otherwise 
1 Patient had at least one of the following symptoms: redness, swelling, sinus tract, wound 
dehiscence, material on view; 2 among them edema (n=6), sinus tract (n=3), chronic 
osteomyelitis (n=3), abscess (n=1) 
 




Positivity rate of different definition criteria and diagnostic tools such as clinical 
presentation, radiology, microbiology, sonication of implant and pathology is shown in 
Figure 18. Each characteristic is evaluated for the complete cohort (grey), for patients 
with an intramedullary internal fixation (blue) and for patients with an extramedullary 
internal fixation (orange). Microbiological analysis in general and sonication of the 
explanted fixation device showed the highest positivity rate (99 patients, 80%). Local 
sings of infection confirming infection such as sinus tract and material on view were 
significantly more often present in infections after intramedullary fixation. Similarly, 
histopathology confirmed infection more often in infections after intramedullary fixation, 
however not reaching significance level. 
 
Figure 18: Comparing the diagnostic tools 
 
1 Including all definitive confirmatory signs for infection such as sinus tract and/or visible 

















































all patients (n=127) intramedullary fixation (n=47) extramedullary fixation (n=80)




Table 7 and Figure 19 show the isolated causative pathogens of the cohort. In 45 cases 
(43%) Staphylococcus aureus was detected, coagulase-negative staphylococci in 29 
(28%), gram-negative bacteria in 23 (22%), anaerobes in 11 (11%), enterococci in 10 
(10%), streptococci in 6 (6%), fungi in 2 (2%) and others in 5 cases (5%). Comparing the 
microbiological results of samples harvested at infection site and at the fracture site during 
index surgery, 17 concordant pathogens and hence persistent infection were 
documented. The persisting infections were caused by Staphylococcus aureus (n=10), 
gram-negative bacteria (n=5). coagulase-negative staphylococci (n=1) and enterococci 
(n=1). No significant difference was shown between the two groups regarding persistent 
infection (57% in the group with intramedullary fixation vs. 67% in the group with 
extramedullary fixation). Of all implant-associated infections 14 were difficult-to-treat as 
pathogens resistant to biofilm-active antimicrobial agents or fungi were detected. In 12 of 
these 14 cases the implant was still in place at admission. Among them, we found 7 
ciprofloxacin-resistant gram-negative bacteria, 4 rifampin-resistant staphylococci (3 
coagulase-negative staphylococci and one Staphylococcus aureus) and 2 Candida spp. 
 










S. aureus 1 45/105 (43) 16/37 (43) 29/67 (43) 1.000 
Coagulase-negative 
staphylococci 2 
30/105 (29) 6/37 (16) 23/67 (34) 0.067 
Gram-negative bacteria 3 23/105 (22) 14/37 (38) 10/67 (15) 0.014 
Anaerobes 4 11/105 (10) 5/37 (14) 6/67 (9) 0.515 




Enterococci 5 10/105 (10) 3/37 (8) 7/67 (10) 1.000 
Streptococci 6 6/105 (6) 2/37 (5) 4/67 (6) 1.000 
Candida parapsilosis 2/105 (2) 1/37 (3) 1/67 (1) 1.000 
Others 7 5/105 (5) 2/37 (5) 3/67 (4) 1.000 
NOTE. Data are no. (%) of episodes, if not indicated otherwise. In patients with 
polymicrobial infections, more than one pathogen per patient was listed, therefore the 
sum exceeds 100% 
1 Including 1 strain resistant to rifampin; 2 Including S. epidermidis (n=20), S. lugdunendis 
(n=5), S. caprae (n=1), S. haemolyticus (n=1), S. hominis (n=1), S. warneri (n=1), S. 
capitis (n=1); among them 3 strains resistant to rifampin; 3 Including E. coli (n=6), 
Pseudomonas spp. (n=6), Klebsiella spp. (n=5), Enterobacter (n=5), Actinobacter spp. 
(n=3), Proteus mirabilis (n=2), Aeromonas species (n=1), Serratia marescens (n=1), 
Morganella morganii (n=1); among them 7 resistant to ciprofloxacin; 4 Including 
Cutibacterium acnes (n=4), Clostridium spp. (n=2), Lactobacilus species (n=1), 
Paenipacillus species (n=1), Finegoldia magna (n=1), Peptoniphilus asacharolyticus 
(n=1), Anaerococcus praevotii (n=1); 5 Including E. faecialis (n=6), E. faecium (n=3), E. 
aerogenes (n=2), E. absuriae (n=1), E. casseliflavus (n=1); 6 Including S. pyogenes (n=2), 
S. mitis (n=1), S. dysgalacticae (n=1), S. vestibularis (n=1), S. parasanguinis (n=1), S. 
gordonii (n=1), S. sobrinus (n=1); 7 Including Bacillus cereus (n=2), Corynebacterium 









Figure 19: Causative pathogens of the cohort 
 
 
 3.4  Treatment 
The surgical and antimicrobial treatment of the patients is summarized in Table 8. All but 
one patient received surgical treatment. In one case no surgery was performed, due to 
the expected non-adherence in the post-surgical care. Out of the 126 surgical treatments 
40 patients (32%) received debridement and retention of the implant, in 43 cases (34%) 
the implant was permanently removed, 36 patients received an exchange of the implant 
performing either a 1-stage (n=16, 13%) or 2-stage procedure (n=20, 16%). In the cases 
treated with a 2-stage procedure the median time between removal of the internal fixation 
and implantation of a new device was 70 days (range from 3 to 144 days). In 7 patients 
(6%) the affected extremity was amputated. When the cohort of patients with no implant 
(n=31) is seen separately, debridement was done in 28 patients, one patient received a 
two- staged procedure with a spacer and for two patients an amputation of the affected 
limb was necessary. The frequencies of the different surgical procedures performed in 























fixation were treated more commonly with retentions of the device compared to infections 
after extramedullary fixation (47% versus 23%, p=0.006), plates and screws were 
significantly more often exchanged in one stage (16% vs. 6%, p=0.027). In median one 
surgical procedure was performed, with a range from 0 to 11 surgeries. Antimicrobial 
treatment was given in 120 cases (94%). The antimicrobial treatment was adequate in 85 
(71%) and inadequate in 35 (29%) cases. 
 










No surgery 1 (1) - 1/80 (1) 1.000 
Surgical treatment 126 (99) 47/47 (100) 79/80 (99) 1.000 
Debridement (and 
implant retention) 
40/126 (32) 22/47 (47) 18/79 (23) 0.006 
Removal 43/126 (34) 13/47 (28) 30/79 (38) 0.252 
1-stage 16/126 (13) 3/47 (6) 13/79 (16) 0.027 




70 (3 - 144) 73 (44-117) 70 (3-144) 0.841 
Amputation 7/126 (6) 4/47 (9) 3/79 (4) 0.423 
Number of surgeries, 
median (range) 
1 (0-11) 1 (1-7) 1 (0-11) 0.960 
Antimicrobial treatment 120 (94) 45/46 (98) 75/79 (95) 0.651 




Adequate 85/120 (71) 33/45 (73) 52/75 (69) 0.683 
Inadequate 35/120 (29) 12/45 (27) 23/75 (31) 0.683 
NOTE. Data are no. (%) of episodes, if not indicated otherwise 
 




 3.5  Outcome analysis 
 3.5.1  Outcome 
Follow-up was available for 111 patients (87%) and the median follow-up time was 5.2 
months with a range of 0.2 to 85.9 months. In 78 cases (70%) the infection was cured at 
follow-up. Failure regarding infection cure occurred in 33 cases (30%), among them 19 
had persistent (i.e. caused by the same pathogen plus possibly additional pathogens) 






































intramedullary fixation (n=47) extramedullary fixation (n=80)














Follow-up 111/127 (87) 41/47 (87) 70/80 (88) 1.000 
Time, median 
(range) - months 
5,2 (0,2 - 85,9) 5,2 (0,2-85,9) 5,2 (0,3-83,8) 0.503 
Infection success 78/111 (70) 29/41 (71) 49/70 (70) 1.000 
Failure 33/111 (30) 12/41 (29) 21/70 (30) 1.000 
Persistence¹ 19/33 (58) 9/12 (75) 10/21 (48) 0.160 
Reinfection² 14/33 (42) 3/12 (25) 11/21 (52) 0.160 
NOTE. Data are no. (%) of episodes, if not indicated otherwise 
¹ Including S. aureus (n=8) among them 1 resistant to rifampin strain, Enterococcus spp. 
(n=3), Pseudomonas aeruginosa (n=2), Cutibacterium acnes (n=1), S. lugdunensis (n=1);  
² Including S. aureus (n=8) among them 1 resistant to rifampin strain, Enterococcus spp. 
(n=2), Cutibacterium acnes (n=1), coagulase-negative staphylococcus (n=1), Prevotella 
disiens (n=1), Klebsiella pneumoniae (n=1) 
 
Subanalysis was performed to compare the outcome of patients treated before and after 
implementation of the standardized comprehensive treatment in April 2013 (see Table 
10). Follow-up of patients before the implementation of the concept was available for 37 
of 43 (90%) patients, among them successful treatment was documented for 20 (54%) 
patients. Failure regarding infection cure occurred in 17 cases (46%), among them 9 had 
persistent and 8 patients relapsing infection.  




In the patient cohort between 2013 and 2017, 74 (86%) patients were available for a 
follow-up: 58 (78%) patients had a successful treatment and in 16 (22%) cases the 
treatment failed. The infection failure was due to a persistent infection in 10 cases and 
due to a reinfection in 6 cases. 
 
Table 10: Comparison of infection outcome before and after implementation of a 







Follow-up available 37/43 (90) 74/86 (86) 1.000 
Infection success 20/37 (54) 58/74 (78) 0.015 
Failure 17/37 (46) 16/74 (22) 0.015 
Persistence 9/17 (53) 10/16 (63) 0.728 
Reinfection 8/17 (47) 6/16 (38) 0.728 
NOTE. Data are no. (%) of episodes, if not indicated otherwise 
 
When comparing the success of the patients before and after the implementation of the 
standardized treatment concept a significant improvement was seen. (p=0.015) The 
overall success was defined as absence of an infection and at the same time no impaired 
function of the limb.  
 
 3.5.2  Analysis of treatment failures  
Out of the 127 patients 33 (30%) had a treatment failure concerning infection eradication 
i.e. persistent or a new infection. In this group of treatment failure were 24 men (71%). In 
28 cases (85%) the lower and in 5 cases (15%) the upper extremity was affected. 10 




patients (30%) suffered of a concomitant septic arthritis. The reason for the internal 
fixation was for 22 patients (65%) a fracture (open fracture n=14, closed fracture n=8). 
Six patients (18%) suffered from a polytrauma. A chronic infection was present in 26 
(79%) and an acute infection in 6 (18%) cases. Local signs of infection were seen in 26 
patients (79%), the CRP was elevated (>10 mg/l) in 16 patients (47%). The 
microbiological results were positive in 29 cases (monomicrobial n=25, polymicrobial 
n=4). Detected pathogens were Staphylococcus aureus (n=12, 41%), coagulase-
negative staphylococci (n=6, 21%), gram-negative bacteria (n=6, 21%), enterococci (n=4, 
14%), anaerobes (n=2, 7%), streptococci (n=2, 7%), Lactobacillus (n=1, 3%) and among 
them were 3 were resistant to biofilm-active antimicrobials. Four cases (12%) remained 
culture-negative. The surgical treatment was debridement for 14 patients (42%), removal 
of the implant for 7 (21%), 1-stage procedure for 6 (18%) and 2-stage procedure for 5 
(15%) patients. Of interest, in those 11 patients undergoing debridement and implant 
retention, the treatment failed in terms of infection eradication in 5 out of 6 cases with 
chronic infections, whereas the treatment was successful in 4 out of 5 patients with acute 
infection. The antimicrobial treatment was adequate in 7 and inadequate in 4 cases. 
The univariate analysis of patient-, procedure-, infection- and treatment-associated risk 
factors showed immediate internal fixation, inadequate antimicrobial treatment and 
treatment before implementation of a standardized treatment concept to be a risk factor 
for infection failure (Table 11). Patients with an immediate external fixation showed a 
higher rate of treatment failure (44%), compared to the patients with immediate internal 
fixation (20%) (p=0.02). Among the patients with an infection failure, 16 (52%) received 
inadequate antimicrobial treatment. There was a significant difference (p=0.003) in the 
treatment outcome, whether the patient got an adequate or inadequate antimicrobial 
treatment. In the group treated before the implementation of a standardized treatment 




concept, infection failure occurred in 46% of the patients and in those treated after 
implementation, infection failure was noted in 22% (p=0.02). 
 
Table 11: Risk factor analysis of 33 cases with infection failure 
 
Factor present 
(No. of patients with 
factor + infection 
failure/ no. of patients 
with factor)  
Factor absent 
(No. of patients without 
factor + infection 




Age >70 years 5/16 (31) 28/95 (29) 1.000 
Diabetes mellitus 6/17 (35) 27/94 (29) 0.576 
BMI >30 kg/m² 10/27 (37) 23/80 (29) 0.473 
Concomitant septic arthritis 10/33 (26) 23/78 (29) 0.218 
Upper extremity 5/13 (38) 28/111 (25) 0.329 
Open fracture 14/40 (35) 10/38 (26) 0.467 
Polytrauma 6/18 (33) 12/51 (24) 0.534 
Immediate internal fixation 17/83 (20) 12/27 (44) 0.023 
Positive microbiology at 
index surgery 
8/25 (32) 5/19 (26) 0.749 
Intramedullary fixation 12/43 (28) 21/84 (25) 0.256 
Acute infection 6/21 (29) 26/104 (25) 0.786 
Chronic infection 26/104 (25) 7/23 (30) 0.605 
CRP >10 mg/l 16/64 (25) 10/49 (20) 0.655 
Local signs of infection 15/52 (29) 18/75 (24) 0.545 




Sinus tract 11/46 (24) 21/81 (26) 0.835 









One-stage exchange 7/14 (50) 26/97 (27) 0.115 
Two-stage exchange 5/19 (26) 28/92 (30) 0.790 
Debridement 8/24 (33) 25/87 (29) 0.801 
Monomicrobial infection 25/74 (34) 8/35 (23) 0.273 
Polymicrobial infection 4/18 (22) 29/91 (32) 0.776 
Culture -negative infection 4/17 (24) 29/92 (32) 0.580 
Infection with S. aureus 13/44 (30) 20/67 (30) 1.000 
Infection with gram-
negative bacteria 
10/26 (38) 23/85 (27) 0.328 
Difficult-to-treat infections 4/14 (29) 29/97 (30) 1.000 
Inadequate antibiotic 
treatment 
16/31 (52) 17/79 (22) 0.003 
Before implementation of 
standardized treatment 
concept 
17/37 (46) 16/74 (22) 0.015 
NOTE. Data are no. (%) of episodes, if not indicated otherwise 
 
In Tables 12 and 13 separate risk factors of treatment failure for patients with initial 
intramedullary and extramedullary fixation are shown. For the patients with treatment 
failure after intramedullary fixation no significant risk factors was found. The analysis 
showed two significant risk factors for the patient cohort with extramedullary fixation. In 




this group a treatment failure was significantly more often if the fixation device remained 
in situ and if there was inadequate antimicrobial treatment. Patients with an 
extramedullary fixation and retention of the implant had a higher rate of failure (80%) than 
patients with a different surgical therapy (26%). The outcome was significantly different 
(p=0.03). Inadequate antimicrobial treatment was also a risk factor for patients with 
extramedullary fixation (p=0.02). 
 
Table 12: Risk factor analysis of cases with infection failure (n= 12), intramedullary 
fixation 
 
Factor present Factor absent p-value 
Age >70 years 3/5 (60) 9/36 (25) 0.140 
Diabetes mellitus 3/6 (50) 9/35 (26) 0.334 
BMI >30 kg/m² 2/7 (29) 10/31 (32) 1.000 
Concomitant septic arthritis 2/9 (22) 10/32 (31) 0.702 
Upper extremity 0 12/40 (30) 1.000 
Open fracture 7/22 (32) 3/11 (27) 1.000 
Polytrauma 2/8 (25) 3/14 (21) 1.000 
Immediate external fixation 4/8 (50) 7/27 (26) 0.226 
Immediate internal fixation 7/27 (26) 4/8 (50) 0.226 
Positive microbiology at index 
surgery 
2/6 (33) 2/9 (22) 1.000 
Acute infection 1/5 (20) 11/36 (31) 1.000 
Chronic infection 11/36 (31) 1/5 (20) 1.000 
CRP > 10 mg/l 7/22 (32) 4/17 (23) 0.725 




Local signs of infection 8/19 (42) 4/22 (18) 0.168 
Sinus tract 5/22 (23) 7/19 (37) 0.493 









One-stage exchange 1/2 (50) 11/35 (31) 1.000 
Two-stage exchange 1/5 (20) 11/36 (31) 1.000 
Monomicrobial infection 10/27 (37) 2/14 (14) 0.170 
Polymicrobial infection 2/7 (26) 10/34 (29) 1.000 
Culture -negative infection 0 12/34 (35) 0.543 
Infection with S. aureus 7/18 (39) 5/23 (22) 0.307 
Infection with gram-negative 
bacteria 
4/12 (33) 8/29 (28) 0.721 
Difficult-to-treat infections 1/2 (50) 10/37 (27) 0.490 
Inadequate antibiotic treatment 5/10 (50) 6/29 (21) 0.109 
Before implementation of 
standardized treatment concept 
6/12 (50) 6/29 (21) 0.128 
NOTE. Data are no. (%) of episodes, if not indicated otherwise 
 
Table 13: Risk factor analysis of cases with infection failure (n=21), extramedullary 
fixation 
 
Factor present Factor absent p-value 
Age >70 years 2/11 (18) 19/59 (32) 0.485 
Diabetes mellitus 3/11 (27) 18/59 (31) 1.000 




BMI >30 kg/m² 8/20 (40) 14/50 (28) 0.397 
Concomitant septic arthritis 9/25 (36) 14/47 (30) 0.606 
Upper extremity 5/13 (38) 16/57 (24) 0.511 
Open fracture 7/16 (44) 8/25 (32) 0.517 
Polytrauma 4/9 (44) 9/28 (32) 0.691 
Immediate external fixation 8/17 (47) 10/44 (23) 0.115 
Immediate internal fixation 10/44 (23) 8/17 (47) 0.115 
Positive microbiology at index 
surgery 
6/18 (33) 3/7 (43) 0.673 
Acute infection 5/13 (38) 15/55 (27) 0.503 
Chronic infection 15/55 (27) 5/13 (38) 0.503 
CRP >10 mg/l 9/33 (27) 6/26 (23) 0.771 
Local signs of infection 7/25 (28) 14/45 (31) 1.000 
Sinus tract 6/19 (32) 15/51 (29) 1.000 









One-staged exchange 6/12 (50) 15/58 (26) 0.163 
Two-staged exchange 4/14 (29) 17/56 (30) 1.000 
Monomicrobial infection 15/44 (34) 6/23 (26) 0.587 
Polymicrobial infection 2/10 (20) 19/57 (33) 0.487 
Culture -negative infection 4/13 (31) 17/54 (31) 1.000 
Infection with S. aureus 6/26 (23) 15/44 (34) 0.422 
Infection with gram-negative 
bacteria 
6/14 (43) 15/56 (27) 0.329 




Difficult-to-treat infections 3/12 (25) 19/60 (32) 0.744 
Inadequate antibiotic treatment 11/21 (52) 11/50 (22) 0.023 
Before implementation of 
standardized treatment concept 
11/25 (44) 10/43 (23) 0.103 
NOTE. Data are no. (%) of episodes, if not indicated otherwise 
 





4.1 Summary of results 
We reviewed 127 patients (89 men, 38 women) with infection after internal fixation with a 
median age of 53 years (range, 19 to 89 years). In 87% the lower extremity was affected. 
An acute infection (≤6 weeks after internal fixation) was documented in 21 (17%), chronic 
infection was present in 104 patients (83%). At admission, 4% had fever, 43% pain and 
75% local signs of infection (swelling, erythema, sinus tract, wound dehiscence, material 
on view). Infections were monomicrobial in 86 (68%), mixed in 19 (15%) and culture-
negative in 21 patients (17%). Most common pathogens were Staphylococcus aureus 
(43%), coagulase-negative staphylococci (29%) and gram-negative bacteria (22%). 
Debridement (with retention of the implant, if applicable) was performed in 40 patients 
(32%), device removal in 43 (34%), one-stage exchange of osteosynthesis in 16 (13%) 
and two-stage exchange in 20 patients (16%). In one patient, no surgery and in 7 patients, 
amputation of the affected limb was performed. The median follow-up time was 5.2 
months (range 0.2-86 months), 16 (13%) were lost to follow-up. Relapsing or persistent 
infection was observed in 33 patients (30%). Among the 78 infection-free patients, 26 
(33%) reported impaired functional outcome (nonunion, Girdlestone situation or 
amputation of the limb).  
 
4.2 Interpretation of results 
 4.2.1 Interpretation of patient and infection site characteristics 
The described patient cohort depict a typical traumatological population with a 
predominance of male sex (70%), mostly otherwise healthy and with a median age of 53 
years. In average, patients had two revisions on the affected extremity before they were 




admitted because of infection to our hospital. A quarter of the patients suffered from 
comorbidities, only 18 (14%) of diabetes mellitus. The latter was not a significant risk 
factor, as opposed to the results of the study of Kuehl et al., who detected diabetes 
mellitus as a significant risk factor (89). Already in 55% of the index surgeries a positive 
microbiological result was present. Unfortunately, data on the taken consequences based 
on these results is missing and the impact on applied preemptive treatment could not be 
assessed.  
 
 4.2.2 Interpretation of infection characteristics  
At diagnosis of infection, most of the patients (76%) still had the implant in place. The 
median time from the initial implantation of the internal fixation until the onset of infection 
was 10.9 months (327 days). In contrast to our results a similar study of Trampuz et al. 
from 2005 showed a median time interval of 44 days between the index surgery and the 
diagnosis (45). A possible explanation for this observation may be the better detection of 
low grade infections manifesting delayed or late by improved knowledge of diagnostic 
methods and available novel microbiological methods (e.g. sonication). In our study 104 
patients (83%) were admitted with a chronic infection. The classification in acute (≤6 
weeks) and chronic (>6 weeks) was applied because the implemented treatment 
algorithm included this gradation. In contrast to that Metsemakers et al. postulated that 
for the definition of fracture-related infections there should be no subdivision due to a lack 
of scientific evidence and for the reason of simplification. However, Metsemakers et al. 
described a consent regarding different entities in acute and chronic infections and 
therefore different treatment approaches (26). In the resent study of Kuehl et al. instead 
a classification in to early (0-2 weeks after implantation), delayed (3-10 weeks) and late 
(>10 weeks) was chosen to depict the different clinical presentations and variation of 




pathogens (89). Overall, our study showed that acute or chronic infections are not a 
significant risk factor for a treatment failure. Further subanalysis were not reasonable due 
to the small cohort of patients with an acute infection and available follow-up (n=18).  
Of note, infections after extramedullary fixation presented significantly earlier than the 
infections after intramedullary fixation (median of 7 vs 24.9 months, p=0.027). Reasons 
for this observation may be the extent of soft tissue involvement causing an earlier 
manifestation of the, in most cases perioperatively acquired infection, in infections after 
extramedullary fixation. In our study 75% of the patients had local signs of infection such 
as redness, swelling, wound dehiscence, sinus tract or material on view. Patients with an 
intramedullary fixation presented more often with a sinus tract, a wound dehiscence was 
more common when an extramedullary device was used. In the diagnostics of a 
periprosthetic joint infection sinus tract with material on view is a major criteria (90, 91). 
In the patient cohort with an extramedullary internal fixation the implant was significantly 
more often already explanted before the diagnosis of an infection, respectively referral to 
our institution, than in cases with an intramedullary fixation (84% vs. 62% p=0.010). Pain 
was not even mentioned in half of the cohort (43%). An elevated level of CRP (>10 mg/dl) 
was detected in 64 cases (58%). Due to the low sensitivity of a single CRP value, the 
dynamics of this laboratory test should be followed (40). The radiological imaging was 
postulated as important for the diagnosis of internal fixation-associated infection, for 
evaluation of the condition of the implant and for the healing process of the bone (40, 55). 
Our study detected nonunion in 43%, a loose implant in 23%, sequestrum in 3% and other 
signs in 9% of the cases. This supports the consent that radiological imaging is a 
supportive diagnostic tool, but mostly not able to detect the infection by itself. 
Histopathology was only done in 58 cases, 28 (48%) of those were positive. This low 
sensitivity in our small cohort of histopathological testing stays in contrast to the study of 




Morgenstern et al., who postulated an 80% sensitivity of histopathological results (81). In 
comparison of the different diagnostic tools, microbiology was most sensitive, with a 
positive detection rate of 80%.  
The infections were mainly caused by a single pathogen (n=86, 68%). In a few cases the 
infections were polymicrobial (15%) and in 21 (16%) cases no pathogen was detected. 
This is in line with the study of Kuehl et al. showing polymicrobial infections in 29.8% (89). 
Among the detected pathogens Staphylococcus aureus was found in 43%, coagulase-
negative staphylococci in 39% and gram-negative bacteria in 22%. All other pathogens 
were less common. This correlates with other studies, which detected Staphylococcus 
aureus as the most frequent pathogen, coagulase-negative staphylococci as the second 
commonest, followed by gram-negative bacteria.(45, 92, 93) In the study of Torbert et al. 
the second commonest pathogen were gram-negative bacteria (94). Kuehl et al. showed 
a differentiation of the pathogen pattern in terms of early or late infections. In their study 
Staphylococcus aureus was as well the most common pathogen (42%) followed by 
Enterobacteriaceae (27%) in early infections, coagulase-negative staphylococci (39%), 
anaerobes (17%) and streptococci (11%) were more frequent in late infections (89). 
 
 4.2.3 Interpretation of treatment 
The treatment of internal fixation device-associated infections consists of a surgical 
therapy on the one hand and an antimicrobial treatment on the other hand. The goal of 
the treatment is the consolidation of the bone and the prevention of a chronic infection. In 
contrast to periprosthetic joint infections, infection eradication is not the treatment target 
in all patients. The option of infection suppression until removal of the implant to allow for 
bone healing with subsequent explanation of the foreign material is a feasible strategy for 
specific situations (2, 5, 85, 95, 96). Even though conservative therapy is approached, 




debridement with removal of dead tissue is necessary and needs to be performed in every 
case (2). 
In our patient cohort 99% received a surgical treatment. Metsemakers et al. declare that 
sole antimicrobial treatment is an option in an early infection (0-2 weeks) (1). One patient 
of our cohort did not receive a surgical therapy due to expected non-compliance and non-
adherence in the post-surgical care and follow-up. For this patient, the treatment plan was 
a suppression of the infection until the implant could be removed. Eventually the patient 
was lost to follow-up as expected. 
If the infection is acute, the implant is stable and the bone is adequately repositioned but 
not consolidated yet, the treatment option is debridement and retention of the implant in 
addition to an antimicrobial treatment for 12 weeks (see Figure 16). In 40 cases of our 
study this regime was done; significantly more often in patients with an intramedullary 
fixation (47%) than in those with an extramedullary fixation (23%, p=0.006)). Retention of 
the implant might have been more often possible in cases with an intramedullary fixation 
due to less wound dehiscence and therefore a higher chance of primary skin closure. 
(see Figure 16) From pathogenetic point of view, no adequate debridement of the 
medullary canal is possible in this situation and therefore it is not considered first choice 
when an intramedullary implant is in place. In the prospective observational cohort study 
of Tschudin-Sutter et al. all patients received debridement, retention of the implant and 
antibiotic treatment. In their study it was possible to choose this treatment plan due to the 
strict inclusion criteria for the 233 patients, including acute symptoms (≤3 weeks), intact 
soft tissue and only causative pathogens which were susceptible to antimicrobial agents 
(93). No discrimination of intramedullary and extramedullary implants was done in this 
analysis. In our analysis regarding risk factors for failure, retention of the implant was 
seen to be associated with higher probability of infection failure, due to the low number of 




patients it only reached statistically significant level in patients with extramedullary fixation 
and not in intramedullary fixation devices. These observations need to be interpreted 
carefully, as the biofilm age and its impact on treatment strategy is not taken in to account, 
i.e. also chronic infections with a mature biofilm were treated with retention.  
If the bone is already consolidated, removal of the implant in combination with an 
antimicrobial therapy for 6 weeks is a convenient treatment strategy. In our study 43 
patients received this treatment option. Metsemakers et al. describe that there is a high 
chance of clearing the infection once the implant with its biofilm is removed (1). Trampuz 
et al. also recommended a complete removal and external fixation in cases of resistant 
or difficult-to-treat pathogens (2). In contrast to that Al-Mayahi et al. did not see different 
results whether the implant was retained or removed (92).  
Another treatment option is the exchange of the implant, which can be performed in a 
one-stage or two-stage procedure. A one-stage surgery was done for 16 and a two-stage 
procedure for 20 of our patients. The treatment algorithm recommends a one-stage 
exchange in a chronic infection, with the presence of good soft tissue condition and the 
absence of difficult-to-treat pathogens. The one-stage surgery was significantly more 
often performed in the cases with an extramedullary fixation (16% versus 6%, p=0.027). 
A two-stage exchange is to be done in an acute infection with an instable implant, a poor 
repositioning of the bone and a bad soft tissue condition and also in a chronic infection 
with compromised soft tissue and difficult-to-treat pathogens.  
7 of our 127 patients received amputation of the infected limb. In rare cases with severe 
infections and repeated treatment failures, this might be the only option (1). 
The antimicrobial treatment was classified into adequate and inadequate through the 
current knowledge of bioavailability and bactericidal effects of the antimicrobial agents 
and additionally regarding the duration of application. An adequate antimicrobial 




treatment was performed in 71%. The implemented standardized treatment algorithm at 
our hospital advices to give antibiotics for 6 weeks when the implant is removed, 
otherwise for 12 weeks or in cases of suppressive treatment until the implant is removed 
(see Figure 16). Kuehl et al. used an antimicrobial treatment concept for 12 weeks which 
was derived from the treatment plan of prosthetic-joint infections by Zimmerli et al. (60, 
89) and similar to the one applied in our cohort. 
 
 4.3 Outcome analysis 
We had a follow-up of 111 patients (87%) with a median follow-up time of 5.2 months. 
The overall success rate was 48%, 41% in the cohort of patients with an intramedullary 
internal fixation and 51% in the cohort of patients with an extramedullary internal fixation. 
In comparison to that Tschudin-Sutter et al. had a higher success rate of 90% in the 
prospective observational cohort study. This significantly better result was amongst other 
things possible to achieve due to the strict inclusion criteria of the study (93). In the 
retrospective cohort study of Trampuz et al. a success rate of 88% after two years of 
follow-up was achieved (45). The success rate of 87-90% in the study of Kuehl et al. was 
amongst other things possible due to strict exclusion criteria. Patients who suffered of a 
septic nonunion or received an amputation were not included in their study (89). In 
contrast, in our study we assessed the functional outcome in patients who had a 
successful infection eradication. Among the patients of our study with an infection 
success (n=77), were 25 with a function failure which was defined as nonunion, a 
Girdlestone situation or amputation. In the patient cohort with an infection failure, 59% 
were due to a persistent infection and 41% due to a reinfection with other pathogens. 
Those stricter inclusion criteria of the above-mentioned studies can bereasons why the 
success rate of our study cohort is inferior compared to theirs.  




When the follow-up was analyzed separately for the time period before and since the 
implementation of the comprehensive treatment algorithm the success rate varied 
significantly. It increased from a 33% success rate before 2013 to a 56% success rate 
since the implementation of the standardized treatment algorithm. This was a significant 
improvement of the outcome (p=0.03). The question is still, why the success rate is 
roughly above 50%. In our analysis, following risk factors were significant: initial external 
fixation (p=0.04), inadequate antibiotic treatment (p=0.03) and no standardized treatment 
concept (p=0.02). It can be discussed if the initial external fixation as itself is a risk factor, 
or if the circumstances leading to an initial external fixation are the risk factors. Probably 
patients with a more complicated fracture, a worse soft tissue condition and maybe a 
polytrauma do not receive an internal fixation right away, but an immediate external 
fixation. All these aspects may lead to a treatment failure. The risk factors of the 
inadequate antimicrobial treatment and the absence of a comprehensive treatment 
algorithm partly overlap and could be one risk factor. The comprehensive treatment 
concept considered the duration of the infection and the maturity of the biofilm. In cases 
of a young biofilm retention of the implant was a possible treatment concept and on the 
other hand exchange of the implant was recommended in chronic infections. These 
recommendations were leaned on the treatment concept of periprosthetic joint infections 
(60, 96). Of interest, one-staged exchange of the implant was seen to be a risk factor 
(p=0.03) and crystallized as one of the significant risk factors for failure in infections after 
extramedullary fixation (p=0.01). Overall, there was no significant difference in the overall 
and infection success between the patients of intramedullary an extramedullary internal 
fixation. 
 




 4.4 Evaluation of the new treatment concept 
Since the implementation of the standardized treatment concept, the infection and 
functional outcome was improved significantly (55% overall success rate versus 35%, 
p=0.03). The implementation of the new concept might have shown a higher success rate 
due to the interdisciplinary cooperation in the team. A team of experienced and 
specialized experts was put together. The treatment concept included amongst other 
things knowledge of the maturity of the biofilm and suitable antibiotic treatment. Still the 
overall success rate was not as good as desirable. A reason for this might be, the distorted 
patient cohort. It is to be expected that there was a higher amount of severe and complex 
cases at our institution, as national referral center for musculoskeletal infections.  
 
4.5 Impact for clinical practice 
This study shows that it is necessary to reevaluate the diagnostic and treatment strategies 
of internal fixation-associated infections in the clinical practice. The diagnosis is difficult 
and therefor clinical, radiological, microbiological, laboratory and histopathological results 
have to be considered. Because of the lack of symptoms, the infection is often diagnosed 
delayed, especially in cases with an intramedullary fixation. The importance of 
microbiology and sonication must be emphasized. Therefor the samples must be 
collected adequately to achieve informative results.  
The surgical treatment must be chosen, regarding to the state of the bone and its stability. 
Because inadequate antimicrobial treatment was detected as a risk factor, a correct 
antimicrobial treatment strategy is essential. This means that the antimicrobial 
susceptibility testing (antibiogram), the bioavailability and the duration of the application 
have to be taken into account. Furthermore, the antimicrobial treatment needs to fit the 




surgical treatment plan. For example, in cases of retention of the implant the antimicrobial 
substances need to be biofilm active. 
 
4.6 Limitations of this study 
We acknowledge the following limitations to our study. Due to a retrospective study 
design, we face missing data.  
Additionally, the patient cohort was heterogeneous regarding the cause for internal 
fixation with a predominance of fracture related indications and the infection type with a 
predominance of chronic infections.  
The main limitation of this study is that there was only a short-term and passive follow-
up. This needs to be considered due to the conclusion we make and the clinical 
recommendations we give, based on the follow-up data. The time span of the follow-up 
ended with the second incident in the patient’s medical history after the initiation of the 
treatment at our institution. Therefor the time span was often short in cases of an 
immediate failure due to a new or recurrent infection. The follow-up also does not take 
into account possible long-term failures – recurrent infections - of patients, who were 
counted as infection free during our study. It also does not consider the possible low 
sensitivity of the diagnostic tools. The follow-up collected data on objective outcomes 
such as infections, nonunion, amputation and arthrodesis of the bone. A subjective 
functional impaired outcome was not considered. Only a passive follow-up was performed 
due to the assumption that patients with further complications or ongoing infections would 
return to our tertiary healthcare center due to the complexity of their cases. Nevertheless, 
we cannot make certain theses about the patients who were lost to follow-up. 
Larger patient population size in each of the categories examined and an approximately 
equal distribution in both cohorts could have provided additional power to our conclusions. 




Furthermore, we cannot rule out unmeasured variables as possible incompliance with the 
treatment regime. Treatment could only be assessed during hospitalization; after 
discharge of the patient we were not able to monitor the compliance. 




5  Conclusion 
We described clinical features and outcome of infections after fixation of long bones in a 
complex patient population of a referral center for septic surgery. Approximately half of 
the infections after internal fixation of long bones failed in terms of infection eradication 
or restoration of function. No significant differences between intramedullary and 
extramedullary internal fixation was observed in infection success. After implementation 
of an interdisciplinary team applying a standardized surgical and antibiotic treatment 
concept, the infection outcome improved significantly. Even if the infection free survival 
could be improved, the failure rate is still too high. More research for diagnostic tools and 
treatment options is needed. 
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